; (4) regularly assess the efficiency of the administrative mechanism in rapidly allocating funds to support evidence-based substance use disorder treatment services in the areas of greatest need within the eligible local area; (5) work with local public health agencies to determine the size and demographics of the population of individuals with substance use disorders and the types of substance use that are most prevalent in the eligible local area; (6) work with local public health agencies to determine the needs of such population, including the need for substance use disorder treatment services; (7) work with local public agencies to determine the disparities in access to services among affected subpopulations and historically underserved communities, including infrastructure and capacity shortcomings of providers that contribute to these disparities; (8) work with local public agencies to establish methods for obtaining input on community needs and priorities, including by partnering with organizations that serve targeted communities experiencing high opioid related health disparities to gather data using culturally attuned data collection methodologies; (9) coordinate with Federal grantees that provide substance use disorder treatment services within the eligible local area; and (10) annually assess the effectiveness of the substance use disorder treatment services being supported by the grant received by the eligible local area, including— (A) reductions in the rates of overdose and death from substance use disorders; (B) rates of discontinuation from substance use disorder treatment services; (C) long-term outcomes among individuals receiving treatment for substance use disorders